INTEGRATED BIOPHARMA INC Annual Depreciation in USD from 2012 to 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Integrated Biopharma Inc quarterly/annual Depreciation history and growth rate from 2012 to 2024.
  • Integrated Biopharma Inc Depreciation for the quarter ending June 30, 2024 was $87K, a 3.57% increase year-over-year.
  • Integrated Biopharma Inc Depreciation for the twelve months ending June 30, 2024 was $319K, a 9.12% decline year-over-year.
  • Integrated Biopharma Inc annual Depreciation for 2024 was $319K, a 9.12% decline from 2023.
  • Integrated Biopharma Inc annual Depreciation for 2023 was $351K, a 4.46% increase from 2022.
  • Integrated Biopharma Inc annual Depreciation for 2022 was $336K, a 0.3% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $319K -$32K -9.12% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-20
2023 $351K +$15K +4.46% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-20
2022 $336K -$1K -0.3% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-15
2021 $337K +$25K +8.01% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-13
2020 $312K +$24K +8.33% Jul 1, 2019 Jun 30, 2020 10-K 2021-09-02
2019 $288K +$49K +20.5% Jul 1, 2018 Jun 30, 2019 10-K 2020-09-23
2018 $239K -$53K -18.2% Jul 1, 2017 Jun 30, 2018 10-K 2019-08-29
2017 $292K +$46K +18.7% Jul 1, 2016 Jun 30, 2017 10-K 2018-09-12
2016 $246K -$22K -8.21% Jul 1, 2015 Jun 30, 2016 10-K 2017-09-01
2015 $268K +$15K +5.93% Jul 1, 2014 Jun 30, 2015 10-K 2016-09-02
2014 $253K -$36K -12.5% Jul 1, 2013 Jun 30, 2014 10-K 2015-09-04
2013 $289K -$70K -19.5% Jul 1, 2012 Jun 30, 2013 10-K 2014-09-08
2012 $359K Jul 1, 2011 Jun 30, 2012 10-K 2013-09-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.